178 related articles for article (PubMed ID: 14529399)
1. Dual COX inhibition and upper gastrointestinal damage.
Skelly MM; Hawkey CJ
Curr Pharm Des; 2003; 9(27):2191-5. PubMed ID: 14529399
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of COX-1 and/or COX-2 inhibition for the distal gastrointestinal tract.
Lanas A; Panés J; Piqué JM
Curr Pharm Des; 2003; 9(27):2253-66. PubMed ID: 14529405
[TBL] [Abstract][Full Text] [Related]
3. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
Bertolini A; Ottani A; Sandrini M
Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of inhibition OF COX-2 and COX-3 in gastrointestinal damage induced by NSAID in rats ].
Laudanno OM; San Miguel P; Aramberry LJ; Cesolari JA
Acta Gastroenterol Latinoam; 2003; 33(4):183-5. PubMed ID: 14708469
[TBL] [Abstract][Full Text] [Related]
5. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
6. Impact of COX-2 inhibitors in common clinical practice a gastroenterologist's perspective.
Lehmann FS; Beglinger C
Curr Top Med Chem; 2005; 5(5):449-64. PubMed ID: 15974940
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastrointestinal injury and repair: a window of opportunity for cyclooxygenase-inhibiting nitric oxide donors.
Perini R; Fiorucci S; Wallace JL
Can J Gastroenterol; 2004 Apr; 18(4):229-36. PubMed ID: 15054499
[TBL] [Abstract][Full Text] [Related]
8. COX-2-selective inhibitors (COXIBs): gastrointestinal safety.
Pronai L; Hritz I; Molnar B; Herszenyi L; Tulassay Z
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):23-30. PubMed ID: 14552701
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
Whittle BJ
Fundam Clin Pharmacol; 2003 Jun; 17(3):301-13. PubMed ID: 12803569
[TBL] [Abstract][Full Text] [Related]
11. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?
Feldman M; McMahon AT
Ann Intern Med; 2000 Jan; 132(2):134-43. PubMed ID: 10644275
[No Abstract] [Full Text] [Related]
12. COX-1 and COX-2 inhibitors.
Hawkey CJ
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):801-20. PubMed ID: 11566042
[TBL] [Abstract][Full Text] [Related]
13. COX-2 inhibition versus gastroprotection with dual COX inhibitors: an evidence-based approach.
Thompson AJ; Yeomans ND
Curr Pharm Des; 2003; 9(27):2221-8. PubMed ID: 14529403
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase and nitric oxide systems in the gut as therapeutic targets for safer anti-inflammatory drugs.
Whittle BJ
Curr Opin Pharmacol; 2004 Dec; 4(6):538-45. PubMed ID: 15525540
[TBL] [Abstract][Full Text] [Related]
15. COX-2 inhibition, H. pylori infection and the risk of gastrointestinal complications.
Chan FK
Curr Pharm Des; 2003; 9(27):2213-9. PubMed ID: 14529402
[TBL] [Abstract][Full Text] [Related]
16. COX-2 inhibitors. What is their place?
McGettigan P
Aust Fam Physician; 2000 Sep; 29(9):847-52. PubMed ID: 11008387
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal safety of selective COX-2 inhibitors.
Hawkey CJ; Skelly MM
Curr Pharm Des; 2002; 8(12):1077-89. PubMed ID: 11945152
[TBL] [Abstract][Full Text] [Related]
18. COX-2-Selective NSAIDs: new and improved?
Lichtenstein DR; Wolfe MM
JAMA; 2000 Sep; 284(10):1297-9. PubMed ID: 10980759
[No Abstract] [Full Text] [Related]
19. Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs.
Bjarnason I; Scarpignato C; Holmgren E; Olszewski M; Rainsford KD; Lanas A
Gastroenterology; 2018 Feb; 154(3):500-514. PubMed ID: 29221664
[TBL] [Abstract][Full Text] [Related]
20. Prevention of cancer in the upper gastrointestinal tract with COX-inhibition. Still an option?
Jiménez P; García A; Santander S; Piazuelo E
Curr Pharm Des; 2007; 13(22):2261-73. PubMed ID: 17691999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]